C.M. Bidwell & Associates’s Doximity DOCS Stock Holding History

C.M. Bidwell & Associates’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,990	Closed	-$177K	–	493
2025 Q4	$177K	Sell	3,990 -137	-3%	-$7.69K	0.08%	146
2025 Q3	$302K	Sell	4,127 -308	-7%	-$20.1K	0.15%	90
2025 Q2	$272K	Sell	4,435 -200	-4%	-$11.2K	0.14%	100
2025 Q1	$269K	Buy	+4,635	New	+$293K	0.16%	96

Other funds holding DOCS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

C.M. Bidwell & Associates's DOCS Position: Q1 2026 in Review

C.M. Bidwell & Associates sold out of Doximity (DOCS) in Q1 2026, closing a stake of 3,990 shares — an estimated $177K sold.

C.M. Bidwell & Associates first reported a position in DOCS in Q1 2025 and held it in 4 quarters. The position peaked at $302K in Q3 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

C.M. Bidwell & Associates reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
C.M. Bidwell & Associates sold 3,990 Doximity shares in Q1 2026, an estimated $177K.
C.M. Bidwell & Associates first reported a position in Doximity in Q1 2025 and held it in 4 quarters.
C.M. Bidwell & Associates's Doximity position peaked at $302K in Q3 2025.
419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.